论文信息 - Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes - 字舞流文

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes

P. Lip | A. Mitra | S. Elsherbiny | A. Kumar | Q. Alfahad

[1] S. Whitcup,et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. , 2011, Investigative ophthalmology & visual science.

[2] H. Tabandeh,et al. DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS , 2011, Retina.

[3] K. Csaky,et al. Vitreous VEGF clearance is increased after vitrectomy. , 2010, Investigative ophthalmology & visual science.

[4] Alissar Nehmé,et al. Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. , 2008, Investigative ophthalmology & visual science.

[5] M. Figueroa,et al. SURGICAL AND ANATOMICAL OUTCOMES OF PARS PLANA VITRECTOMY FOR DIFFUSE NONTRACTIONAL DIABETIC MACULAR EDEMA , 2008, Retina.